Phillip Fitzsimmons
@Hennion & Walsh Asset Management, Inc.
Latest period2024 - Q4ReportedManaged Assets$2.209BTotal holdings851
Assets growth rate3.15%Assets growth rate (2-Q avg)6.59%Continuous growth in asset value5 quarters
Portfolio positions
This chart displays the top 10 holdings in Hennion & Walsh Asset Management, Inc.'s 2024 - Q4 portfolio, based on their 13F SEC filing, out of a total of 851 positions.
Assets under management
The assets under management (AUM) of Hennion & Walsh Asset Management, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 5 quarters. As of the latest 13F SEC filing for 2024 - Q4, they manage 2.209B in assets, with a quarterly growth rate of 3.15% and a 2-quarter average growth rate of 6.59%. The portfolio is managed by Phillip Fitzsimmons, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
HPEHewlett Packard Enterprise C
| 0.04% | $800,433 37,491 shares@ $21.36 avg price | New Position |
SOUNSoundhound Ai Inc
| 0.04% | $756,023 38,106 shares@ $19.84 avg price | New Position |
ETNB89bio Inc
| 0.04% | $738,943 94,494 shares@ $7.82 avg price | New Position |
MHIPioneer Municipal High Incom
| 0.04% | $735,948 79,476 shares@ $9.27 avg price | New Position |
PRTAProthena Corp Plc
| 0.04% | $724,133 52,284 shares@ $13.85 avg price | New Position |
APOApollo Global Mgmt Inc
| 0.04% | $704,242 4,264 shares@ $165.16 avg price | New Position |
IQLTIshares Tr
| 0.04% | $665,302 17,923 shares@ $37.13 avg price | New Position |
KALVKalvista Pharmaceuticals Inc
| 0.03% | $633,785 74,827 shares@ $8.48 avg price | New Position |
BYRNByrna Technologies Inc
| 0.03% | $615,814 21,375 shares@ $28.82 avg price | New Position |
AUTLAutolus Therapeutics Plc
| 0.03% | $610,953 259,980 shares@ $2.35 avg price | New Position |